Related Experiment Video
Updated: Mar 8, 2026

Adaptation of Semiautomated Circulating Tumor Cell CTC Assays for Clinical and Preclinical Research Applications
Published on: February 28, 2014
Lessons Learned: Transfer of the High-Definition Circulating Tumor Cell Assay Platform to Development as a
P Kuhn1, S M Keating2, G T Baxter2
1The Scripps Research Institute, La Jolla, California, USA.
Abstract:
Planning and transfer of a new technology platform developed in an academic setting to a start-up company for medical diagnostic product development may appear daunting and costly in terms of complexity, time, and resources. In this review we outline the key steps taken and lessons learned when a technology platform developed in an academic setting was transferred to a start-up company for medical diagnostic product development in the interest of elucidating development toolkits for academic groups and small start-up companies starting on the path to commercialization and regulatory approval.

